Login Join for free
Popular Searches
Popular news More >
SEARCHING....
no results found
  • Real Time Chart Real Time Chart
  • Stock Profile Stock Profile

  • Financials As Reported

    • accession Number 0000875320-23-000012
    • accounts Payable Current 323,200,000
    • accounts Receivable Net Current 1,547,800,000
    • accumulated Other Comprehensive Income Loss Net Of Tax --13,100,000
    • allocated Share Based Compensation Expense 122,400,000
    • amendment Flag false
    • assets 18,974,200,000
    • assets Current 12,965,700,000
    • cash And Cash Equivalents At Carrying Value 9,289,900,000
    • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 9,295,600,000
    • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect --1,216,400,000
    • cik 875,320
    • city Area Code 617
    • common Stock Par Or Stated Value Per Share 0.01
    • common Stock Shares Authorized 500,000,000
    • common Stock Shares Issued 257,509,761
    • common Stock Shares Outstanding 257,509,761
    • comprehensive Income Net Of Tax 685,900,000
    • contract With Customer Liability 236,400,000
    • cost Of Goods And Services Sold 266,900,000
    • current Fiscal Year End Date --12-31
    • date Filed 2023-05-02
    • depreciation Depletion And Amortization 38,800,000
    • document Fiscal Period Focus Q1
    • document Fiscal Year Focus 2,023
    • document Period End Date 2023-03-31
    • document Transition Report false
    • document Type 10-Q
    • earnings Per Share Basic 2.72
    • earnings Per Share Diluted 2.69
    • effective Income Tax Rate Continuing Operations 0.215
    • employee Service Share Based Compensation Tax Benefit From Compensation Expense 40,600,000
    • entity Address Address Line 1 50 Northern Avenue
    • entity Address City Or Town Boston
    • entity Address Postal Zip Code 2,210
    • entity Address State Or Province MA
    • entity Central Index Key 875,320
    • entity Current Reporting Status Yes
    • entity Emerging Growth Company false
    • entity File Number 000-19319
    • entity Filer Category Large Accelerated Filer
    • entity Incorporation State Country Code MA
    • entity Interactive Data Current Yes
    • entity Name VERTEX PHARMACEUTICALS INC / MA
    • entity Registrant Name VERTEX PHARMACEUTICALS INC / MA
    • entity Shell Company false
    • entity Small Business false
    • entity Tax Identification Number 04-3039129
    • finance Lease Liability Noncurrent 417,600,000
    • income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 891,500,000
    • income Taxes Paid Net 120,300,000
    • income Tax Expense Benefit 191,700,000
    • increase Decrease In Accounts Payable 35,700,000
    • increase Decrease In Accounts Receivable 90,500,000
    • increase Decrease In Inventories 82,600,000
    • increase Decrease In Other Operating Liabilities 89,400,000
    • interest Paid Net 11,100,000
    • inventory Net 535,100,000
    • investment Income Interest And Dividend 122,600,000
    • irs Number 43,039,129
    • liabilities 4,541,900,000
    • liabilities And Stockholders Equity 18,974,200,000
    • liabilities Current 3,026,200,000
    • local Phone Number 341-6100
    • marketable Securities Current 1,124,200,000
    • marketable Securities Noncurrent 1,081,500,000
    • net Cash Provided By Used In Financing Activities --294,700,000
    • net Cash Provided By Used In Investing Activities --1,833,600,000
    • net Cash Provided By Used In Operating Activities 899,900,000
    • net Income Loss 699,800,000
    • operating Income Loss 779,000,000
    • operating Lease Liability Noncurrent 371,600,000
    • operating Lease Right Of Use Asset 336,300,000
    • other Assets Noncurrent 427,500,000
    • other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent --13,900,000
    • other Liabilities Current 377,000,000
    • other Liabilities Noncurrent 726,500,000
    • other Noncash Income Expense --21,700,000
    • other Nonoperating Income Expense 1,300,000
    • payments For Repurchase Of Common Stock 132,800,000
    • payments Related To Tax Withholding For Share Based Compensation 166,600,000
    • payments To Acquire Available For Sale Securities Debt 1,816,600,000
    • payments To Acquire Property Plant And Equipment 42,100,000
    • period End 1,680,220,800,000
    • period Start 1,672,531,200,000
    • proceeds From Maturities Prepayments And Calls Of Available For Sale Securities 50,000,000
    • proceeds From Payments For Other Financing Activities 1,100,000
    • report Link https://www.sec.gov/Archives/edgar/data/875320/000087532023000012/vrtx-20230331_htm.xml
    • retained Earnings Accumulated Deficit 7,222,600,000
    • revenue From Contract With Customer Excluding Assessed Tax 2,374,800,000
    • selling General And Administrative Expense 241,100,000
    • share Based Compensation 122,400,000
    • stockholders Equity 14,432,300,000
    • trading Symbol VRTX
    • unrecognized Tax Benefits That Would Impact Effective Tax Rate 232,200,000
    • update 1970-01-01
    • weighted Average Number Of Diluted Shares Outstanding 260,300,000
    • weighted Average Number Of Shares Outstanding Basic 257,400,000
    • id REPORTED_FINANCIALS
    • key VRTX
    • subkey 10-Q
    • date 2023-05-02
    • updated 2023-05-03
  • Symbol Info Symbol Info
  • Symbol Over View Symbol Over View
  • Technical Analysis Technical Analysis

VRTX stock fundamentals - financials as reported

Financials As Reported

  • accession Number 0000875320-23-000012
  • accounts Payable Current 323,200,000
  • accounts Receivable Net Current 1,547,800,000
  • accumulated Other Comprehensive Income Loss Net Of Tax --13,100,000
  • allocated Share Based Compensation Expense 122,400,000
  • amendment Flag false
  • assets 18,974,200,000
  • assets Current 12,965,700,000
  • cash And Cash Equivalents At Carrying Value 9,289,900,000
  • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 9,295,600,000
  • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect --1,216,400,000
  • cik 875,320
  • city Area Code 617
  • common Stock Par Or Stated Value Per Share 0.01
  • common Stock Shares Authorized 500,000,000
  • common Stock Shares Issued 257,509,761
  • common Stock Shares Outstanding 257,509,761
  • comprehensive Income Net Of Tax 685,900,000
  • contract With Customer Liability 236,400,000
  • cost Of Goods And Services Sold 266,900,000
  • current Fiscal Year End Date --12-31
  • date Filed 2023-05-02
  • depreciation Depletion And Amortization 38,800,000
  • document Fiscal Period Focus Q1
  • document Fiscal Year Focus 2,023
  • document Period End Date 2023-03-31
  • document Transition Report false
  • document Type 10-Q
  • earnings Per Share Basic 2.72
  • earnings Per Share Diluted 2.69
  • effective Income Tax Rate Continuing Operations 0.215
  • employee Service Share Based Compensation Tax Benefit From Compensation Expense 40,600,000
  • entity Address Address Line 1 50 Northern Avenue
  • entity Address City Or Town Boston
  • entity Address Postal Zip Code 2,210
  • entity Address State Or Province MA
  • entity Central Index Key 875,320
  • entity Current Reporting Status Yes
  • entity Emerging Growth Company false
  • entity File Number 000-19319
  • entity Filer Category Large Accelerated Filer
  • entity Incorporation State Country Code MA
  • entity Interactive Data Current Yes
  • entity Name VERTEX PHARMACEUTICALS INC / MA
  • entity Registrant Name VERTEX PHARMACEUTICALS INC / MA
  • entity Shell Company false
  • entity Small Business false
  • entity Tax Identification Number 04-3039129
  • finance Lease Liability Noncurrent 417,600,000
  • income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 891,500,000
  • income Taxes Paid Net 120,300,000
  • income Tax Expense Benefit 191,700,000
  • increase Decrease In Accounts Payable 35,700,000
  • increase Decrease In Accounts Receivable 90,500,000
  • increase Decrease In Inventories 82,600,000
  • increase Decrease In Other Operating Liabilities 89,400,000
  • interest Paid Net 11,100,000
  • inventory Net 535,100,000
  • investment Income Interest And Dividend 122,600,000
  • irs Number 43,039,129
  • liabilities 4,541,900,000
  • liabilities And Stockholders Equity 18,974,200,000
  • liabilities Current 3,026,200,000
  • local Phone Number 341-6100
  • marketable Securities Current 1,124,200,000
  • marketable Securities Noncurrent 1,081,500,000
  • net Cash Provided By Used In Financing Activities --294,700,000
  • net Cash Provided By Used In Investing Activities --1,833,600,000
  • net Cash Provided By Used In Operating Activities 899,900,000
  • net Income Loss 699,800,000
  • operating Income Loss 779,000,000
  • operating Lease Liability Noncurrent 371,600,000
  • operating Lease Right Of Use Asset 336,300,000
  • other Assets Noncurrent 427,500,000
  • other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent --13,900,000
  • other Liabilities Current 377,000,000
  • other Liabilities Noncurrent 726,500,000
  • other Noncash Income Expense --21,700,000
  • other Nonoperating Income Expense 1,300,000
  • payments For Repurchase Of Common Stock 132,800,000
  • payments Related To Tax Withholding For Share Based Compensation 166,600,000
  • payments To Acquire Available For Sale Securities Debt 1,816,600,000
  • payments To Acquire Property Plant And Equipment 42,100,000
  • period End 1,680,220,800,000
  • period Start 1,672,531,200,000
  • proceeds From Maturities Prepayments And Calls Of Available For Sale Securities 50,000,000
  • proceeds From Payments For Other Financing Activities 1,100,000
  • report Link https://www.sec.gov/Archives/edgar/data/875320/000087532023000012/vrtx-20230331_htm.xml
  • retained Earnings Accumulated Deficit 7,222,600,000
  • revenue From Contract With Customer Excluding Assessed Tax 2,374,800,000
  • selling General And Administrative Expense 241,100,000
  • share Based Compensation 122,400,000
  • stockholders Equity 14,432,300,000
  • trading Symbol VRTX
  • unrecognized Tax Benefits That Would Impact Effective Tax Rate 232,200,000
  • update 1970-01-01
  • weighted Average Number Of Diluted Shares Outstanding 260,300,000
  • weighted Average Number Of Shares Outstanding Basic 257,400,000
  • id REPORTED_FINANCIALS
  • key VRTX
  • subkey 10-Q
  • date 2023-05-02
  • updated 2023-05-03

Related News

Intel Sold $15B of Stock at a 175% Gain and the Anchor Foundry Customer Still Has No Name

Intel Sold $15B of Stock at a 175% Gain and the Anchor Foundry Customer Still Has No Name

Itai Smidt 10.08.26
Stocks INTC MU NVDA AMD
MP Materials Rips 9% to $51 on 89% Revenue Growth — $41M EBITDA Swing Still Leaves It 48% Below $100

MP Materials Rips 9% to $51 on 89% Revenue Growth — $41M EBITDA Swing Still Leaves It 48% Below $100

Itai Smidt 10.08.26
Stocks MP USAR UUUU AREC
Wall Street Freezes at All-Time Highs as Closed Hormuz Fights a Minus 23,000 Payrolls Print

Wall Street Freezes at All-Time Highs as Closed Hormuz Fights a Minus 23,000 Payrolls Print

Itai Smidt 10.08.26
Stocks Markets VRTX HPE AAPL MU
SPY Reclaims $772 on the Payrolls Miss: Best Earnings Season on Record With 29% of the Fund in 5 Names

SPY Reclaims $772 on the Payrolls Miss: Best Earnings Season on Record With 29% of the Fund in 5 Names

Itai Smidt 07.08.26
Stocks Markets AAPL NVDA GOOGL MSFT
Chevron Nearly Quintuples Profit to $12.1B and Trades Below the Print: 21.4% ROCE, Record 1.07M bpd Refining

Chevron Nearly Quintuples Profit to $12.1B and Trades Below the Print: 21.4% ROCE, Record 1.07M bpd Refining

Itai Smidt 07.08.26
Stocks CVX XOM BP PBR
Exxon Mobil Doubles Profit to $14.5B and Still Sits 12% Below Its High: Permian Hits 1.8M Barrels a Day

Exxon Mobil Doubles Profit to $14.5B and Still Sits 12% Below Its High: Permian Hits 1.8M Barrels a Day

Itai Smidt 07.08.26
Stocks XOM CVX BP PBR
Trade Now
© Trading News. All Rights Reserved Since 2022